product pipeline / R&D affecting expense
“Year Ended December 31, 2025 2024 Revenue 100 % 100 % Cost of revenue 26 % 26 % Gross margin 74 % 74 % Operating expenses: Research and development 28 % 33 % Sales and marketing 55 % 56 % General and administrative 19 % 21 % Total operating expenses 102 % 110 % Loss from operations (28 )% (36 )% Other income (expense), net 3 % 5 % Loss before provision for (benefit from) income taxes (25 )% (31 )% Provision for (benefit from) income taxes 1 % 1 % Net loss (26 )% (32 )% Note: Certain figures may not sum due to rounding 60 Comparison of Fiscal Years Ended December 31, 2025 and 2024 Revenue Year Ended December 31, 2025 2024 $ Change % Change (in thousands, except percentages) Revenue $ 343,214 $ 299,272 $ 43,942 15 % Revenue increased $43.9 million or 15%, in the year ended December 31, 2025 compared to the year ended December 31, 2024.”
AMPL 10-K